Related Experiment Video
Updated: Jan 9, 2026

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion
Published on: April 4, 2025
Epithelial-mesenchymal dynamics in cancer: Role of signalling pathways, stromal interactions and natural therapies
Iram Khan1, Anindita Behera2, Kamesh R Babu3
1Department of Pharmaceutical Sciences, School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, India.
Background And Purpose:
Epithelial-mesenchymal transition (EMT) and its reverse process, mesenchymal-epithelial transition (MET), play crucial roles in embryogenesis, tissue regeneration, and cancer progression. Dysregulation of EMT/MET pathways in cancer contributes to metastasis and drug resistance.
Approach:
This review discusses the signalling pathways that are correlated with EMT in cancer and investigates the therapeutic potential of naturally occurring compounds in modulating these processes. The intricate relationship between stromal cells, drug resistance, and EMT is discussed, highlighting the emerging role of MET in stabilizing distant metastasis. Additionally, the impact of p53 on EMT and its implications in cancer metastasis are discussed. The review also provides an overview of therapeutic molecules, both plant- and animal-derived, that regulate EMT, highlighting their potential in cancer treatment. Specifically, plant-based compounds from Atractylodes lancea, Dendrobium officinale, Panax ginseng and Platycodon grandiflorus, as well as animal-derived substances like bee venom and snake venom, are highlighted. Furthermore, marine-based compounds, including caprolactin C, laminaran sulfate, BFP-3, bryostatin 1, sinulariolide, manzamines, halichondrin B, eribulin and biemamides, exhibit significant anti-metastatic effects by targeting EMT-associated pathways.
Conclusion:
The diverse range of therapeutic molecules discussed in this review provides promising therapeutic avenues for developing targeted strategies against EMT in cancer.
Insights
This review explores how epithelial-mesenchymal transition (EMT) drives cancer metastasis and drug resistance. It highlights natural compounds from plants, animals, and marine sources that can target EMT pathways for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Epithelial-mesenchymal transition (EMT) and its reverse (MET) are vital in development and disease.
- Dysregulation of EMT/MET pathways in cancer promotes metastasis and drug resistance.
Purpose of the Study:
- To review signaling pathways correlated with EMT in cancer.
- To investigate therapeutic potential of natural compounds in modulating EMT.
- To discuss the role of MET in metastasis and p53's impact on EMT.
Main Methods:
- Literature review of signaling pathways involved in EMT.
- Analysis of naturally occurring compounds (plant, animal, marine) targeting EMT.
- Examination of the relationship between stromal cells, drug resistance, and EMT.
Main Results:
- Identified various plant-derived compounds (e.g., from Panax ginseng) with anti-EMT potential.
- Highlighted animal-derived substances (e.g., bee venom) and marine compounds (e.g., eribulin) with anti-metastatic effects.
- Emphasized MET's role in stabilizing metastasis and p53's influence on EMT.
Conclusions:
- Diverse therapeutic molecules show promise for targeted anti-EMT strategies in cancer.
- Natural compounds offer potential for novel cancer treatments by modulating EMT.
Related Concept Videos
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mesenchymal Stem Cells
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Non-Canonical Wnt Signaling Pathways
Mitogens and the Cell Cycle

